iroGates Investors

ViroGates follows an active investment strategy by looking for ‘intelligent’ capital.  Our investors follow our activities closely and the majority have active roles in the company.

Our current investors include:

   1. The Way Forward ApS 
   2. Forward Capital A/S  
   3. Missionpharma A/S  
   4. BioVision A/S  
   5. Pepperholm Partners  
   6. JEO Holding ApS   
   7. Further unnamed Private Investors

If you are interested to know more about ViroGates and investing, please contact our CFO, May Britt Dyvelkov, at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

 

ViroGates A/S

ri_6.jpg

Meet Us

We are routinely participating in international partnering and sales conferences.

For further details please visit www.suparnostic.com or call us at +45 3698 0645.


News

Latest Article:

"ViroGates - Measuring blood in the health care sector in Kenya..."                

 

"Dansk opfindelse kan fange sygdomssignaler i opløbet...."                                                                              

 

Latest Press Releases:

ViroGates launches suPARnostic® Quick Triage product....                                                                                 

 

ViroGates receives product approval in Canada
and enters into distribution agreement with Cedarlane....